KPIs & Operating Metrics(New)
Assets By SegmentBreakdown Of AssetsContractual Obligations AnnualCost Of SalesEmployee StatisticsGross Margin %Gross ProfitIncome Before Income TaxInternational Revenue BreakdownMed Surg And Neurotechnolgy Revenue By GeographyMedsurg And Neurotechnology Revenue By Geography AnnualMed Surg Revenue By CategoryMed Surg Revenue By Category AnnualMed Surg Revenue By Geography Annual (Deprecated)Med Surg Revenue By Geography (Deprecated)Neurotechnology And Spine Revenue By Category AnnualNeurotechnology And Spine Revenue By Category (Deprecated)Neurotechnology And Spine Revenue By Geography Annual (Deprecated)Neurotechnology And Spine Revenue By Geography (Deprecated)Non Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Income By SegmentOperating Income By Segment AnnualOperating Margin By Segment %Operating Margin By Segment Annual %OPEX As A% Of Total Revenue %OPEX SegregationOrthopaedics And Spine Revenue By GeographyOrthopaedics And Spine Revenue By Geography AnnualOrthopaedics Revenue By CategoryOrthopaedics Revenue By Category AnnualOrthopaedics Revenue By Geography Annual (Deprecated)Orthopaedics Revenue By Geography (Deprecated)Property, Plant And Equipment, Net BreakdownProperty, Plant And Equipment, Net By GeographyRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By ProductRevenue By Product %Revenue By Product AnnualRevenue By Product Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Stryker (SYK) Gross Profit (2009 - 2026)

Stryker (SYK) reported Gross Profit of $3.8 billion for Q1 2026, up 1.76% year-over-year from $3.7 billion in Q1 2025, and down 17.68% on a QoQ basis from $4.6 billion in Q4 2025.

Stryker (SYK) has 18 years of Gross Profit data on file, last reported at $3.8 billion in Q1 2026.

  • Quarterly Gross Profit rose 1.76% year-over-year to $3.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.1 billion (up 8.62% YoY) and the FY2025 annual result came in at $16.1 billion, up 11.25% from the prior year.
  • Gross Profit fell to $3.8 billion in Q1 2026 per SYK's latest filing, from $4.6 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $4.6 billion in Q4 2025 and bottomed at $2.7 billion in Q1 2022.
  • The 5-year median for Gross Profit is $3.4 billion (2024), against an average of $3.5 billion.
  • The widest annual swing landed in 2023, when Gross Profit rose 14.43%; it then increased 1.76% in 2026.
  • Tracing SYK's Gross Profit over 5 years: stood at $3.2 billion in 2022, then climbed by 14.43% to $3.7 billion in 2023, then rose by 12.72% to $4.2 billion in 2024, then grew by 10.88% to $4.6 billion in 2025, then declined by 17.68% to $3.8 billion in 2026.
  • Per Business Quant, the three latest SYK Gross Profit figures stand at $3.8 billion (Q1 2026), $4.6 billion (Q4 2025), and $3.9 billion (Q3 2025).